The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

CHEMBL7550     8-ethyl-3,5-dimethyl-9-[[4- [2-(2H-tetrazol...

Synonyms: SureCN683357, SureCN5344127, CHEBI:102725, DNC011714, LS-193980, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of L158809

  • In addition, L158809 did not alter the pressor response to hypoxia, whereas responses to angiotensin II were reduced in a selective manner.(ABSTRACT TRUNCATED AT 250 WORDS)[1]

High impact information on L158809

  • Two months later, they were treated for two months with: 1) vehicle; 2) AT(1)-ant (L158809, Merck, Rahway, New Jersey); 3) AT(1)-ant + AT(2)-ant (PD-123319, Parke Davis, Ann Arbor, Michigan); or 4) AT(1)-ant + kinin B(2) receptor antagonist (B(2)-ant) (icatibant) (only BN) [2].
  • The 0.01-0.1 nM AII-VC unmasked by the potentiating effect of NO inhibition, were sensitive not only to AT1 (L158809), but also to AT2 receptor (PD123319) antagonists [3].
  • 4. In the presence of L-NAME, 500 nM L158809 abolished the Ang II-induced vasoconstrictions whatever the concentration tested [4].
  • The effect of the octapeptide on both frequency and amplitude of the nuclear waves was prevented by the AT1 receptor antagonist L158809 [5].


  1. Influence of N omega-nitro-L-arginine methyl ester, LY83583, glybenclamide and L158809 on pulmonary circulation. Feng, C.J., Cheng, D.Y., Kaye, A.D., Kadowitz, P.J., Nossaman, B.D. Eur. J. Pharmacol. (1994) [Pubmed]
  2. Role of angiotensin II type 2 receptors and kinins in the cardioprotective effect of angiotensin II type 1 receptor antagonists in rats with heart failure. Liu, Y.H., Yang, X.P., Shesely, E.G., Sankey, S.S., Carretero, O.A. J. Am. Coll. Cardiol. (2004) [Pubmed]
  3. AT2 antagonist-sensitive potentiation of angiotensin II-induced constriction by NO blockade and its dependence on endothelium and P450 eicosanoids in rat renal vasculature. Muller, C., Endlich, K., Helwig, J.J. Br. J. Pharmacol. (1998) [Pubmed]
  4. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature. Muller, C., Endlich, K., Barthelmebs, M., Helwig, J.J. Br. J. Pharmacol. (1997) [Pubmed]
  5. Angiotensin II induced increase in frequency of cytosolic and nuclear calcium waves of heart cells via activation of AT1 and AT2 receptors. Bkaily, G., El-Bizri, N., Nader, M., Hazzouri, K.M., Riopel, J., Jacques, D., Regoli, D., D'Orleans-Juste, P., Gobeil, F., Avedanian, L. Peptides (2005) [Pubmed]
WikiGenes - Universities